drugset / Trial / NCT02616315
Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effect of naltrexone hydrochloride(HCL) and bupropion hydrochloride extended release combination (NB) compared with placebo on weight loss in obese participants post bariatric surgery.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-10
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 360 mg | Oral |
| Subject | Naltrexone | Small molecule | 32 mg | Oral |
Indications
No indication recorded.